TITLE

Correlates between HIV/AIDS Antibody with some Immuno-Hematological Variables of Infected Subjects in Niger Delta Communities

AUTHOR(S)
Azuonwu, O.; Frank-Peterside; Erhabor, O.
PUB. DATE
August 2012
SOURCE
Journal of Applied Pharmaceutical Science;Aug2012, Vol. 2 Issue 8, p85
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The study tend to uncover the epidemiological trend and association of HIV/AIDS with some immuno-hematological profile of infected subjects in Niger Delta. A total of 1000 subjects, made up of 464 males (46.4%) and 536 females (53.6%) were screened. HIV antibodies were detected using "Determine" (Abbott Laboratories, Japan), Start -Pak (Chembio Diagnostics, USA) and SD Bioline HIV-1/2 kits (Standard Diagnostics, Korea).Out of this number, 107(10.7%) were sero-positive. The PCV of HIV positive subjects ranged between 24.00 and 48.00% (32.94±0.53),HB ranged between 8.00 and 16.00g/dl (10.95± 0.18) while WBC counts ranged between 3.30 and 16.30 Mm³(7.76 ±0.30). However, CD4 counts ranged between 210.00 and 937.00µl, with a mean of 480.55 (±13.44). At P<0.01; the PCV correlated positively with HB(r=0.999) and negatively with WBC (r = -0.303), while HB correlated negatively with WBC(r=-0.306). Conversely, CD4 counts did not correlate with any of the parameters. The need for frequent monitoring of the impact of HIV/AIDS on the immunological profile of infected groups in Niger Delta is strongly encourage. This will prevent anemia and other hematological problems.
ACCESSION #
88001334

 

Related Articles

  • Use of CD4 lymphocyte count to predict long term survival free of AIDS after HIV infection. Phillips, Andrew N.; Sabin, Caroline A.; Elford, Jonathan; Bofill, Margarita; Janossy, George; Lee, Christine A. // BMJ: British Medical Journal (International Edition);7/30/94, Vol. 309 Issue 6950, p309 

    Estimates the probability of remaining free of AIDS after infection with HIV by extrapolation of changes in CD4lymphocyte count in Great Britain. Number of survival years for younger patients; Comparison of survival between younger and older patients; Percentage of survival rate after...

  • CD4+ T-Lymphocytopenia without HIV Infection -- No Lights, No Camera, Just Facts. Fauci, Anthony S. // New England Journal of Medicine;2/11/93, Vol. 328 Issue 6, p429 

    The article comments on the current knowledge about the epidemiologic, clinical, immunologic, and virologic aspects of idiopathic CD4+ T-lymphocytopenia, citing various reports within the issue. The author says that multiple studies of blood donors confirm that idiopathic CD4+ T-lymphocytopenia...

  • Estradiol Reduces Susceptibility of CD4+ T Cells and Macrophages to HIV-Infection. Rodriguez-Garcia, Marta; Biswas, Nabanita; Patel, Mickey V.; Barr, Fiona D.; Crist, Sarah G.; Ochsenbauer, Christina; Fahey, John V.; Wira, Charles R. // PLoS ONE;Apr2013, Vol. 8 Issue 4, p1 

    The magnitude of the HIV epidemic in women requires urgent efforts to find effective preventive methods. Even though sex hormones have been described to influence HIV infection in epidemiological studies and regulate different immune responses that may affect HIV infection, the direct role that...

  • CD4 cell counts in adults with newly diagnosed HIV infection in Barbados. Kilaru, Krishna R.; Kumar, Alok; Sippy, Namrata // Revista Panamericana de Salud Publica;Nov2004, Vol. 16 Issue 5, p302 

    Objective. To evaluate the absolute CD4 cell counts of all the newly diagnosed HIV-infected persons who presented at the Ladymeade Reference Unit (LRU), which serves as the national HIV/AIDS referral and treatment center for the country of Barbados. Design and Methods. The study group was...

  • Presentation and reasons for HIV-1 testing in Saudi Arabia. Alrajhi, A. A.; Halim, M. A.; Al-Abdely, H. M. // International Journal of STD & AIDS;Dec2006, Vol. 17 Issue 12, p806 

    Clinical presentation, CD4+ T lymphocyte count at diagnosis, and reasons for HIV-1 testing reflect the attitudes towards HIV testing and also the ability of the health-care system to diagnose HIV early. In a cross-sectional study from the HIV database in a large HIV-referral centre in Saudi...

  • Acquired immunodeficiency without evidence of HIV infection: national retrospective survey. McNulty, A.; Kaldor, J.M.; McDonald, A.M.; Baumgart, K.; Cooper, D.A. // BMJ: British Medical Journal (International Edition);3/26/94, Vol. 308 Issue 6932, p825 

    Presents a national retrospective survey of AIDS without evidence of HIV infection in Australia. Introduction of idiopathic CD4 T lymphocytopenia; Identification and characterized the cases of unexplained CD4 lymphocytopenia; Information of patient diagnosed as immunodeficient.

  • Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Finzi, Diana; Blankson, Joel; Siliciano, Janet D.; Margolick, Joseph B.; Chadwick, Karen; Pierson, Theodore; Smith, Kendall; Lisziewicz, Julianna; Lori, Franco; Flexner, Charles; Quinn, Thomas C.; Chaisson, Richard E.; Rosenberg, Eric; Walker, Bruce; Gange, Stephen; Gallant, Joel; Siliciano, Robert F. // Nature Medicine;May99, Vol. 5 Issue 5, p512 

    Combination therapy for HIV-1 infection can reduce plasma virus to undetectable levels, indicating that prolonged treatment might eradicate the infection. However, HIV-1 can persist in a latent form in resting CD4[sup +] T cells. We measured the decay rate of this latent reservoir in 34 treated...

  • Effects of Virologic Rebound on CD4 Cell Counts. Bahrani, Ashkan; Ramaswamy, Ramesh; Oldfield III, Edward C. // Clinical Infectious Diseases;4/15/2001, Vol. 32 Issue 8, p1231 

    Presents information on a study which examined the effects of virologic rebound on CD4 cell counts in HIV-infected patients. Methodology; Results of the study; Discussion.

  • Is the clinical course of HIV-1 changing? Cohort study. Sinicco, A.; Fora, R. // BMJ: British Medical Journal (International Edition);04/26/97, Vol. 314 Issue 7089, p1232 

    Assesses whether the clinical course of HIV infection has changed from 1985 to 1995. Disease progression; Speed of CD4 cell decline in patients with recently acquired HIV infection.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics